Kelly Hall

Kelly Hall is an experienced professional in clinical development and operations, currently serving as Director of Clinical Development Operations at Aurion Biotech since September 2025, focusing on first-in-class corneal endothelial cell therapies. Prior to this role, Kelly held various positions at Orasis Pharmaceuticals, including Associate Director of Medical Affairs and Associate Director of Clinical Operations, where responsibilities included managing medical education initiatives and leading clinical trials. Previous experience encompasses clinical research roles at Kelly OCG, Glaukos Corporation, and Vance Thompson Vision, demonstrating a commitment to fostering strong relationships with clinical sites and achieving high-quality patient experiences. Kelly holds a Bachelor of Science in Biology from South Dakota State University and has pursued graduate coursework in finance at Liberty University and research administration at Johns Hopkins University.